Document Detail


Factors predicting perioperative cytokine response in patients undergoing liver transplantation.
MedLine Citation:
PMID:  10708165     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: An exaggerated production of proinflammatory cytokines during liver transplantation stimulates the inflammatory process within the graft, and eventually promotes liver failure. This study was conducted to evaluate factors predicting perioperative response of proinflammatory cytokines during liver transplantation. DESIGN: Prospective, consecutive entry study of liver transplant candidates. SETTING: University hospital. PATIENTS: Thirty liver transplant recipients. INTERVENTIONS: Arterial blood samples were obtained perioperatively. MEASUREMENTS: Interleukin (IL)-1beta, IL-6, tumor necrosis factor-alpha were measured by ELISA. Endotoxin was determined by a chromogenic endotoxin-specific method. MAIN RESULTS: The peak concentrations of IL-1beta and IL-6 in the patients with complications were significantly higher than those in the patients without complications. The peak concentration of IL-1beta was significantly correlated with the level of bilirubin at admission and the intraoperative blood product requirement. The peak concentration of IL-6 was significantly correlated with the admission bilirubin and the intraoperative blood product requirement. A multivariate regression model revealed that the serum bilirubin and the intraoperative blood product requirement were the independent factors that influenced the peak concentration of IL-1beta or IL-6. The severely jaundiced patients had a significantly higher plasma concentration of endotoxin at the end of the anhepatic phase. In addition, there was a tendency for these patients to have a higher postoperative peak concentration of endotoxin. CONCLUSIONS: Serum level of bilirubin may be a potent preoperative factor influencing perioperative cytokine response in patients undergoing liver transplantation. An enhanced perioperative response of endotoxin seen in severely jaundiced patients suggests the clinical implication of endotoxin removal during the anhepatic phase in liver transplant surgery.
Authors:
C Miki; P McMaster; A D Mayer; K Iriyama; H Suzuki; J A Buckels
Related Documents :
16610005 - Hyperlactatemia in patients with non-acetaminophen-related acute liver failure.
10343615 - Human herpesvirus 6 latently infects mononuclear cells but not liver tissue.
1127265 - Extraction of antibiotics from the circulation by liver and kidney: effect of probenecid.
16315305 - Activation pattern of mitogen-activated protein kinases in early phase of different siz...
23561635 - Mesenchymal stem cell transplantation to the mouse cochlea as a treatment for childhood...
3541315 - Examination of the clonal deletion hypothesis following transfusions in rat cardiac tra...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Critical care medicine     Volume:  28     ISSN:  0090-3493     ISO Abbreviation:  Crit. Care Med.     Publication Date:  2000 Feb 
Date Detail:
Created Date:  2000-03-16     Completed Date:  2000-03-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0355501     Medline TA:  Crit Care Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  351-4     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery II, Mie University Medical School, Tsu, Japan. harborne@clin.medic.mie-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Bilirubin / blood
Blood Transfusion / statistics & numerical data
Chronic Disease
Endotoxins / blood
Enzyme-Linked Immunosorbent Assay
Female
Humans
Interleukin-1 / blood*
Interleukin-6 / blood*
Liver Cirrhosis / blood,  etiology,  immunology*,  surgery*
Liver Transplantation / adverse effects*,  immunology*
Male
Middle Aged
Multivariate Analysis
Predictive Value of Tests
Prospective Studies
Regression Analysis
Risk Factors
Time Factors
Tumor Necrosis Factor-alpha / metabolism*
Chemical
Reg. No./Substance:
0/Endotoxins; 0/Interleukin-1; 0/Interleukin-6; 0/Tumor Necrosis Factor-alpha; 635-65-4/Bilirubin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The impact of long-term acute-care facilities on the outcome and cost of care for patients undergoin...
Next Document:  Insertion time of the pulmonary artery catheter in critically ill patients.